APA (7th ed.) Citation

Ohanian, M., Ravandi, F., Suarez-Almazor, M. E., Diab, A., Abdel-Wahab, N., Safa, H., . . . Alousi, A. M. (2021, February). Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. Journal for ImmunoTherapy of Cancer.

Chicago Style (17th ed.) Citation

Ohanian, Maro, et al. "Post-transplantation Cyclophosphamide Reduces the Incidence of Acute Graft-versus-host Disease in Patients with Acute Myeloid Leukemia/myelodysplastic Syndromes Who Receive Immune Checkpoint Inhibitors After Allogeneic Hematopoietic Stem Cell Transplantation." Journal for ImmunoTherapy of Cancer Feb. 2021.

MLA (9th ed.) Citation

Ohanian, Maro, et al. "Post-transplantation Cyclophosphamide Reduces the Incidence of Acute Graft-versus-host Disease in Patients with Acute Myeloid Leukemia/myelodysplastic Syndromes Who Receive Immune Checkpoint Inhibitors After Allogeneic Hematopoietic Stem Cell Transplantation." Journal for ImmunoTherapy of Cancer, Feb. 2021.